(NP -LCB-/-LRB- (NP The/DT value/NN) (PP of/IN (NP (NP the/DT clinical/JJ test/NN) (PP of/IN (NP (NP glucocorticoid/NN receptors/NNS) (PP of/IN (NP (NP peripheral/JJ blood/NN leukocytes/NNS) (PP in/IN (NP (NP patients/NNS) (PP with/IN (NP chronic/JJ pulmonary/JJ heart/NN disease/NN)))))))))) -RCB-/-RRB-)
(S (SBAR In/IN order/NN to/TO (S (NP-SBJ */-NONE-) (VP inquire/VB (PP into/IN (NP (NP the/DT functional/JJ state/NN) (PP of/IN (NP (NP adrenal/JJ cortex/NN) (PP in/IN (NP (NP patients/NNS) (PP with/IN (NP pulmonary/JJ heart/NN disease/NN))))))))))) ,/, (S-COOD (S (NP-SBJ-27 (NP the/DT number/NN) (PP of/IN (NP (NP (NP glucocorticoid/NN receptors/NNS) (PRN -LRB-/-LRB- (NP GCR/NN) -RRB-/-RRB-)) (PP of/IN (NP (NP peripheral/JJ blood/NN leukocytes/NNS) (PP in/IN (NP (NP patients/NNS) (PP with/IN (NP chronic/JJ pulmonary/JJ heart/NN disease/NN))))))))) (VP was/VBD (VP determined/VBN (NP *-27/-NONE-) (PP with/IN (NP radioligand-binding/JJ assay/NN))))) and/CC (S (NP-SBJ-28 the/DT corresponding/JJ plasma/NN cortisol/NN levels/NNS) (VP were/VBD (VP assessed/VBN (NP *-28/-NONE-) (PP with/IN (NP radioimmune/JJ assays/NNS)))))) ./.)
(S (NP-SBJ The/DT results/NNS) (VP showed/VBD (SBAR that/IN (S-COOD (S (NP-SBJ-29 (NP the/DT number/NN) (PP of/IN (NP (NP GCR/NN) (PP in/IN (NP the/DT patients/NNS))))) (VP was/VBD (ADVP significantly/RB) (VP reduced/VBN (NP *-29/-NONE-) (PRN -LRB-/-LRB- (S (NP-SBJ P/NN) (NP-PRD (QP &lt;/JJR 0.01/CD))) -RRB-/-RRB-)))) and/CC (S (NP-SBJ-30 it/PRP) (VP was/VBD (VP increased/VBN (NP *-30/-NONE-) (SBAR-TMP (WHADVP-31 when/WRB) (S (NP-SBJ-32 their/PRP$ health/NN state/NN) (VP was/VBD (VP improved/VBN (NP *-32/-NONE-) (ADVP *T*-31/-NONE-))))))))))) ./.)
(S (ADVP However/RB) ,/, (NP-SBJ it/PRP) (VP was/VBD (ADVP still/RB) (ADJP-PRD (ADJP lower/JJR) (PP than/IN (NP (NP that/DT) (PP in/IN (NP healthy/JJ subjects/NNS))))) (PRN -LRB-/-LRB- (S (NP-SBJ P/NN) (NP-PRD (QP &lt;/JJR 0.01/CD))) -RRB-/-RRB-)) ./.)
(S (NP-SBJ-33 (NP The/DT number/NN) (PP of/IN (NP (NP GCR/NN) (PP in/IN (NP the/DT patients/NNS))))) (VP was/VBD (ADVP greatly/RB) (VP increased/VBN (NP *-33/-NONE-) (SBAR-TMP (WHADVP-34 when/WRB) (S (NP-SBJ-35 these/DT patients/NNS) (VP were/VBD (VP treated/VBN (NP *-35/-NONE-) (PP with/IN (NP oxygen/NN)) (ADVP *T*-34/-NONE-))))) (PRN -LRB-/-LRB- (S (NP-SBJ P/NN) (NP-PRD (QP &lt;/JJR 0.01/CD))) -RRB-/-RRB-))) ./.)
(S (NP-SBJ-36 (NP No/DT difference/NN) (PP in/IN (NP plasma/NN cortisol/NN))) (VP was/VBD (VP found/VBN (NP *-36/-NONE-) (PP between/IN (NP-COOD (NP the/DT patients/NNS) and/CC (NP the/DT healthy/JJ subjects/NNS))) (PRN -LRB-/-LRB- (S (NP-SBJ P/NN) (NP-PRD (QP &gt;/JJR 0.05/CD))) -RRB-/-RRB-))) ./.)
(S (NP-SBJ These/DT results/NNS) (VP indicate/VBP (SBAR that/IN (S-COOD (S (NP-SBJ-37 (NP the/DT function/NN) (PP of/IN (NP adrenal/JJ cortex/NN))) (VP may/MD (VP be/VB (VP improved/VBN (NP *-37/-NONE-) (PP by/IN (NP-LGS (NP the/DT compensation/NN mechanism/NN) (PP of/IN (NP the/DT patients/NNS)))))))) ,/, but/CC (S (NP-SBJ the/DT lower/JJR GCR/NN number/NN) (VP was/VBD (NP-PRD (NP the/DT result/NN) (PP of/IN (NP (NP lacking/NN) (PP of/IN (NP oxygen/NN)) (PP in/IN (NP the/DT patients/NNS)))))))))) ./.)
(S (NP-SBJ-38 (NP The/DT number/NN) (PP of/IN (NP GCR/NN))) (VP may/MD (VP be/VB (VP improved/VBN (NP *-38/-NONE-) (PP by/IN (NP-LGS (NP inhalation/NN) (PP of/IN (NP oxygen/NN))))))) ./.)
(S (ADVP Therefore/RB) (NP-SBJ oxygen/NN therapy/NN) (VP is/VBZ (ADJP-PRD helpful/JJ) (PP in/IN (S (NP-SBJ */-NONE-) (VP-COOD (VP raising/VBG (NP (NP the/DT activity/NN) (PP of/IN (NP glucocorticoid/NN receptors/NNS)))) and/CC (VP controlling/VBG (NP (NP the/DT development/NN) (PP of/IN (NP the/DT disease/NN)))))))) ./.)
